Intuitive Surgical, Inc.
Financials
Valuation Metrics
Intuitive Surgical, Inc.'s Market Cap is $154.68B. At end of 2025 it was $201.00B. Ranked #100 of 3,118 in US market (top 3%), #36 of 1,474 on NASDAQ (top 2%), #5 of 203 in Health Care Equipment & Services (top 2%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $154.68B | US#100/3,118 Sec#5/203 |
| Revenue | $11.58B | US#513/3,118 Sec#33/203 |
| Net Income | $2.96B | US#249/3,118 Sec#13/203 |
| Total Assets | $19.35B | US#626/3,118 Sec#29/203 |
| Net Assets | $15.99B | US#282/3,118 Sec#16/203 |
| Employees | 17,021 | US#618/3,118 Sec#45/203 |
| Value | ||
| P/E | 52.31x | US#1,926/3,118 Sec#100/203 |
| P/B | 9.68x | US#2,603/3,118 Sec#164/203 |
| PEG | 6.83x | US#1,203/3,118 Sec#66/203 |
| P/S | 13.36x | US#2,782/3,118 Sec#189/203 |
| EV/EBITDA | 36.20x | US#2,282/3,118 Sec#123/203 |
| FCF Yield | 2.33% | US#1,956/3,118 Sec#117/203 |
| Profitability | ||
| ROE | 18.50% | US#675/3,118 Sec#31/203 |
| ROA | 15.28% | US#225/3,118 Sec#11/203 |
| Op. Margin | 28.36% | US#560/3,118 Sec#13/203 |
| Revenue Growth | 20.45% | US#664/3,118 Sec#39/203 |
| Earnings Growth | 7.66% | US#1,132/3,118 Sec#65/203 |
| Financial Health | ||
| Debt Ratio | 20.21% | US#226/3,118 Sec#21/203 |
| Total Debt | $0.00 | US—/3,118 Sec—/203 |
| FCF | $3.60B | US#225/3,118 Sec#17/203 |
| Cash | $2.98B | US#308/3,118 Sec#16/203 |
| Current Ratio | 3.33x | US#684/3,118 Sec#69/203 |
| Net Debt/EBITDA | -0.71x | US#354/3,118 Sec#29/203 |
| Performance | ||
| 1Y Return | -18.25% | US#2,371/3,118 Sec#159/203 |
| 1M Return | 11.43% | US#1,118/3,118 Sec#94/203 |
| From 52W High | -27.67% | US#1,876/3,118 Sec#145/203 |
| 1Y MDD | -44.00% | US#2,122/3,118 Sec#136/203 |
| Trading | ||
| Volume | 3,198,034 shares | US#869/3,118 Sec#47/203 |
| Trading Value | $1.41B | US#117/3,118 Sec#6/203 |
| Per Share | ||
| EPS | $8.35 | US#375/3,118 Sec#24/203 |
| BPS | $45.14 | US#516/3,118 Sec#35/203 |
Company Info
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.